Searched for
PHARMA BREAKTHROUGHS
'Fastest we've ever put a trade deal into force': British High Commissioner to India Lindy Cameron hails India-UK trade dealThe India-UK Comprehensive Economic and Trade Agreement (CETA) will take effect on July 15, 2026, marking the fastest trade deal implementa...
Pharma in her DNA, Wockhardt scion ready for deep dive in the USZahabiya Khorakiwala is leading Wockhardt's US business and the launch of its new antibiotic, Zaynich. This drug targets resistant bacteria...
Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
'Wait out IT, buy pharma and defence'; Ajay Bagga's 3-sector playbook for 2026Ajay Bagga offers a clear strategy for Indian markets. He advises waiting for real AI revenue in IT. Pharma remains a strong investment due...
Ahead of Market: 10 things that will decide stock market action on TuesdayBenchmark indices Sensex and Nifty fell for a fourth straight session amid elevated crude oil prices, geopolitical tensions and persistent ...
Tata-backed MedTherapy claims CAR-T breakthrough with one-day productionTata Sons-backed biotech startup MedTherapy said it has developed a next-generation CAR-T cell therapy manufacturing platform that can redu...
Geopolitical stability will decide market’s next move: Sandip SabharwalIndian equity markets are holding above 24,000, buoyed by improving sentiment and steady earnings, though geopolitical tensions remain a co...
Ahead of Market: 10 things that will decide stock market action on MondayIndian equity benchmarks closed modestly higher on Friday, with financial stocks leading the gains. The Nifty and Sensex edged up, though p...
Sensex dips 3,400 points in 4 days. Is this the beginning of a bigger crash?Indian equity markets fell for a fourth straight session as rising crude oil prices, geopolitical tensions, FII selling, and a record-low r...
Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
How AI Innovation and Artificial Intelligence products are transforming global industriesAs innovation evolves beyond industry boundaries, the AI Special Product / Innovation category at the ET Most Innovative AI Product Awards ...
What war? Smallcap stocks defy Middle East tensions with up to 56% gains in 2 months as Nifty slidesDespite Middle East tensions and a sliding Nifty50, India's smallcap stocks have surged up to 56% in two months. While institutional desks ...
ET Most Innovative AI Product Awards 2026: Honouring the innovations powering India's next economyThe ET Most Innovative AI Product Awards 2026 brings together 11 distinct categories that reflect where artificial intelligence is deliveri...
USFDA accepts Wockhardt’s NDA for breakthrough antibiotic ZaynichThis is the first time ever that an NDA from a new chemical entity (NCE) from an Indian pharma company has been filed and accepted by the U...
Time has never been better for Pharma breakthroughs than today: Bayer executive Stefan OelrichBayer, the renowned pharmaceutical powerhouse from Germany, is implementing a tiered pricing strategy on a global scale to make medications...
Rhizen's cancer drug Umbralisib gets USFDA nod: Alembic PharmaAlembic Pharma on Tuesday said its associate company Rhizen Pharmaceuticals AG's product Umbralisib, which was licensed to TG Therapeutics,...
Sun Pharma completes acquisition of Ocular Technologies SarlAll the necessary formalities for closure of the said transaction have been concluded and the company has successfully completed the acquis...
Sun Pharma inks pact to develop nervous system drugsThe company will have commercial rights to this product globally. It will also fund all future studies to be conducted on the enzyme.
Government assures all help to boost pharma exportsGovernment assured the pharma industry of "every possible help" in resolving its issues related to exports and said efforts would be made t...
- Indian pharma cos close to blockbuster breakthrough
Indian pharma majors may manage to market their first indi-genous "blockbuster drugs" or new chemical entities (NCEs) in the next four year...